291
Participants
Start Date
July 22, 2019
Primary Completion Date
November 11, 2024
Study Completion Date
November 11, 2024
Cladribine Tablets
No intervention will be administered as a part of this study. Participants will receive cladribine tablets as per investigator discretion and as per United States approved label: 3.5 milligram/kilogram (mg/kg) body weight over 2 years, administered as 1 treatment course of 1.75 mg/kg per year.
The Trustee of Columbia University in the City of New York, New York
NYU Langone Brooklyn - Brooklyn, Brooklyn
DENT Neurologic Institute, Amherst
Wills Eye Institute - Ocular Oncology Service - Wills Eye Institute, Philadelphia
Multiple Sclerosis Center of Greater Washington, Vienna
Integrated Neurology Services - Dr. Simon Fishman's Office, Alexandria
Neurological Associates, Richmond
Massey Cancer Center - VCU Medical Center, Richmond
Sentara Ambulatory Care Center, Virginia Beach
Meridian Clinical Research (Neurology), Norfolk
Blacksburg Neurology, PC, Christiansburg
Guilford Neurologic Associates, Greensboro
The Charlotte-Mecklenburg Hospital Authority - Carolinas Healthcare System, Charlotte
Premier Neurology Research, P.C., Greer
Neurology Associates, P. A., Maitland
Orlando Health Multiple Sclerosis Comprehensive Care Center - Downtown Orlando, Orlando
University of Miami, Miami
Axiom Clinical Research of Florida, Tampa
University of South Florida, Tampa
Suncoast Neuroscience and Associates, Inc., St. Petersburg
North Central Neurology Associates, P.C., Cullman
University of South Alabama, Mobile
Vanderbilt University Medical Center, Nashville
Neurology, PC, Knoxville
Baptist Health Lexington, Lexington
The Boster Center for Multiple Scelosis, Columbus
Insight Neuroscience LLC, Bellevue
Riverhills Neuroscience, Cincinnati
Dayton Center for Neurological Disorders, Dayton
Fort Wayne Neurological Center, Fort Wayne
Wayne State University (WSU) - Multiple Sclerosis Treatment and Clinical Research Center (MS Center) - Department of Neurology, Detroit
Detroit Clinical Research Center, PC, Farmington Hills
Memorial Healthcare, Owosso
Ascension St. Francis Center for Neurological Disorders, S.C., Milwaukee
The Medical College of Wisconsin - Endocrinology, Milwaukee
Neuroscience Group of Northeast Wisconsin - DUPLICATE, Neenah
Minneapolis Clinic of Neurology - Neurology, Golden Valley
Northwest Neurology Ltd, Rolling Meadows
Prairie Education & Research, Springfield
College Park Family Care Center, Overland Park
University of Arkansas for Medical Sciences, Little Rock
Baylor College of Medicine IRB, Houston
Northwest Houston Neurology, Cypress
Neurology Center of San Antonio, San Antonio
DHR Health Neurology Institute Neuroimmunology and Multiple Sclerosis, McAllen
Central Texas Neurology Consultants, Round Rock
HCA Research Institute, Englewood
Advanced Neurosciences Research, LLC, Fort Collins
Colorado Springs Neurological Associates, PC - Neurology, Colorado Springs
Neurology Center of Las Vegas, Las Vegas
Regina Berkovich MD PhD INC, West Hollywood
Fullerton Neurology and Headache Center, Fullerton
Providence Neurological Specialties, Portland
MS Center of Evergreen, Kirkland
MultiCare Health System Institute for Research and Innovation - MultiCare Health System Institute for Research, Tacoma
MultiCare Health System Institute for Research and Innovation - MultiCare Health System Institute for Research and, Spokane
Associated Neurologists of Southern Connecticut, PC, Fairfield
Yale University, Fairfield
Northern Light Comprehensive Multiple Sclerosis Care Center, Bangor
Neurological Clinical Research Institute, Boston
Neuro Institute of New England P.C., Foxborough
The Elliot Lewis Center for Multiple Sclerosis Care, Wellesley
UMASS - Neurology, Worcester
Raleigh Neurology Associates, Raleigh
University of Toledo - PARENT, Toledo
VCU Medical Center - Pediatric Neurology, Richmond
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono Research & Development Institute, Inc.
INDUSTRY